B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Mitolactol

53 PubMed studies analyzed · 8 RCTs · Evidence Score: 46.2

Research Domains

Mitolactol has been studied across 6 research domains including 🔬 Oncology, 😴 Sleep, ⏳ Longevity & Aging, ✨ Skin & Hair, 🫘 Kidney. The primary research focus is 🔬 Oncology with 87% of studies addressing this area.

Loading evidence profile...

This evidence profile for Mitolactol is generated deterministically from 53 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.